Molecularly redefining small bowel adenocarcinoma to accelerate precision patient care – protocol of a multicenter observational cohort biomarker study

Molecularly redefining small bowel adenocarcinoma to accelerate precision patient care – protocol of a multicenter observational cohort biomarker study

Abstract Background Small Bowel Adenocarcinoma (SBA) is a rare gastrointestinal cancer with a limited understanding of the molecular pathology. This study aims to bridge the knowledge gap, providing a robust molecular foundation for SBA and addressing the clinical challenges inherent in treating thi...

Full description

Saved in:
Bibliographic Details
Main Authors: Rasmus Haunstrup Døssing, Julia Johanna Almer Broman, Colm J. O’Rourke, Elizaveta Mitkina Tabaksblat, Jesper Bøje Andersen, Carsten Palnæs Hansen, Tim Svenstrup Poulsen, Estrid V. S. Høgdall, Jakob Hagen Vasehus Schou, Dan Høgdall
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Cancer
Subjects:
Small bowel adenocarcinoma
Consensus molecular subtypes
DNA
RNA
T-cell receptor
Molecular-guided treatment strategies
Online Access:https://doi.org/10.1186/s12885-024-13369-1
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12885-024-13369-1

Similar Items